Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid for Cutaneous Squamous Cell Carcinoma
NCT06644079Phase 2Withdrawn
- Sponsor
- University of Florida
- Start
- May 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tranexamic acid in cutaneous squamous cell carcinoma (cSCC), sponsored by University of Florida. Planned start May 2025; status: withdrawn.
02
Drugs
tranexamic acid
03
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on NCT06644079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06644079.